Work

Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist

Year: 2018

Type: article

Source: Cancer Immunology Research

DOI: 10.1158/2326-6066.cir-18-0222

Authors: Fanny Polesso, Andrew D. Weinberg, Amy E. Moran

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Providence Portland Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Cancer Society, Oregon Health and Science University, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G3132607528, G3478249038, G5780489950, G9000008731, G9000181852

OpenAlex ID: W2903685741

FWCI: 1.607

Cites: 37

Cited by: 45

Related to: 10